Evidence map›Paper›PMID 22777335›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2012

Diagnostic and prognostic correlates of preoperative FDG PET for breast cancer.

Vincent Vinh-Hung, Hendrik Everaert, Jan Lamote, Mia Voordeckers, Hilde van Parijs, Marian Vanhoeij, Guy Verfaillie, Christel Fontaine, Hansjoerg Vees, Osman Ratib and 2 more

Registry-linked trialOpen access · greenAbstract readEvaluation Study
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01432002 (Application of 18F-[FDG] PET/CT to Simulation and Planning of Radiotherapy), which is not on this map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01432002 unknown statusnot on this map

Application of 18F-[FDG] PET/CT to Simulation and Planning of Radiotherapy (RT) for Breast Cancer. Definition of Target Volume for 3-D RT and for Partial Breast Irradiation (PBI) by IMRT Technique

TypeobservationalSponsorUniversity Hospital, GenevaRan2007 to 2023Enrolled60ConditionsBreast Neoplasm
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Pretreatment PET in breast cancer: is there a role?European journal of nuclear medicine and molecular imaging · 2012
    Article
  9. Preoperative FDG PET/CT in breast cancer patients: where are we going?European journal of nuclear medicine and molecular imaging · 2012
    Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

Vincent Vinh-HungDepartment of Imaging and Medical Information Sciences, University Hospitals of Geneva, University of Geneva, Geneva, Switzerland. anhxang@gmail.com
Hendrik Everaert
Jan Lamote
Mia Voordeckers
Hilde van Parijs
Marian Vanhoeij
Guy Verfaillie
Christel Fontaine
Hansjoerg Vees
Osman Ratib
Georges Vlastos
Mark De Ridder
Vrije Universiteit Brussel · BEUniversity Hospital of Geneva · CHUniversity of Geneva · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo explore the preoperative utility of FDG PET for the diagnosis and prognosis in a retrospective breast cancer case series.

methodsIn this retrospective study, 104 patients who had undergone a preoperative FDG PET scan for primary breast cancer at the UZ Brussel during the period 2002-2008 were identified. Selection criteria were: histological confirmation, FDG PET performed prior to therapy, and breast surgery integrated into the primary therapy plan. Patterns of increased metabolism were recorded according to the involved locations: breast, ipsilateral axillary region, internal mammary chain, or distant organs. The end-point for the survival analysis using Cox proportional hazards was disease-free survival. The contribution of prognostic factors was evaluated using the Akaike information criterion and the Nagelkerke index.

resultsPET positivity was associated with age, gender, tumour location, tumour size >2 cm, lymphovascular invasion, oestrogen and progesterone receptor status. Among 63 patients with a negative axillary PET status, 56 (88.9 %) had three or fewer involved nodes, whereas among 41 patients with a positive axillary PET status, 25 (61.0 %) had more than three positive nodes (P < 0.0001). In the survival analysis of preoperative characteristics, PET axillary node positivity was the foremost statistically significant factor associated with decreased disease-free survival (hazard ratio 2.81, 95% CI 1.17-6.74).

conclusionPreoperative PET axillary node positivity identified patients with a higher burden of nodal involvement, which might be important for treatment decisions in breast cancer patients.

Indexed as

Fluorodeoxyglucose F18Positron-Emission TomographyRadiopharmaceuticalsAdultBreast Neoplasms, MaleFemaleHumansLymphatic MetastasisMaleMiddle AgedPreoperative CarePrognosisRetrospective StudiesFluorodeoxyglucose F18Radiopharmaceuticals

Identifiers

PMID22777335
OpenAlexW2015030961

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.